Suppr超能文献

利用肝素递呈纳米纤维捕获干细胞旁分泌效应治疗心血管疾病。

Capturing the stem cell paracrine effect using heparin-presenting nanofibres to treat cardiovascular diseases.

机构信息

Department of Biomedical Engineering, Northwestern University, Evanston, IL, USA.

出版信息

J Tissue Eng Regen Med. 2010 Dec;4(8):600-10. doi: 10.1002/term.273.

Abstract

The mechanism for stem cell-mediated improvement following acute myocardial infarction has been actively debated. We support hypotheses that the stem cell effect is primarily paracrine factor-linked. We used a heparin-presenting injectable nanofibre network to bind and deliver paracrine factors derived from hypoxic conditioned stem cell media to mimic this stem cell paracrine effect. Our self-assembling peptide nanofibres presenting heparin were capable of binding paracrine factors from a medium phase. When these factor-loaded materials were injected into the heart following coronary artery ligation in a mouse ischaemia-reperfusion model of acute myocardial infarction, we found significant preservation of haemodynamic function. Through media manipulation, we were able to determine that crucial factors are primarily < 30 kDa and primarily heparin-binding. Using recombinant VEGF- and bFGF-loaded nanofibre networks, the effect observed with conditioned media was recapitulated. When evaluated in another disease model, a chronic rat ischaemic hind limb, our factor-loaded materials contributed to extensive limb revascularization. These experiments demonstrate the potency of the paracrine effect associated with stem cell therapies and the potential of a biomaterial to bind and deliver these factors, pointing to a potential therapy based on synthetic materials and recombinant factors as an acellular therapy.

摘要

干细胞介导的急性心肌梗死后改善的机制一直备受争议。我们支持这样的假设,即干细胞的作用主要是旁分泌因子相关的。我们使用一种带有肝素的可注射纳米纤维网络来结合和输送来自缺氧条件的干细胞培养基的旁分泌因子,以模拟这种干细胞旁分泌作用。我们的自组装肽纳米纤维能够结合培养基中的旁分泌因子。当这些因子负载的材料在冠状动脉结扎后的缺血再灌注模型中注射到心脏后,我们发现心功能有显著的保存。通过培养基的操作,我们能够确定关键的因子主要是 < 30 kDa,并且主要与肝素结合。使用重组 VEGF 和 bFGF 负载的纳米纤维网络,我们观察到与条件培养基相似的效果。当在另一个疾病模型,慢性大鼠缺血性后肢中进行评估时,我们的因子负载材料有助于广泛的肢体再血管化。这些实验证明了与干细胞治疗相关的旁分泌作用的效力,以及生物材料结合和输送这些因子的潜力,为基于合成材料和重组因子的非细胞治疗提供了一种潜在的治疗方法。

相似文献

引用本文的文献

2
Hierarchical Design of Tissue-Mimetic Fibrillar Hydrogel Scaffolds.层次化设计组织模拟纤维水凝胶支架。
Adv Healthc Mater. 2024 Jun;13(16):e2303167. doi: 10.1002/adhm.202303167. Epub 2024 Apr 30.
4
Translational Applications of Hydrogels.水凝胶的转化应用。
Chem Rev. 2021 Sep 22;121(18):11385-11457. doi: 10.1021/acs.chemrev.0c01177. Epub 2021 May 3.
5
(Macro)molecular self-assembly for hydrogel drug delivery.用于水凝胶药物输送的(宏观)分子自组装。
Adv Drug Deliv Rev. 2021 May;172:275-295. doi: 10.1016/j.addr.2021.01.006. Epub 2021 Jan 12.
8
Peptide-Based Functional Biomaterials for Soft-Tissue Repair.用于软组织修复的基于肽的功能性生物材料。
Front Bioeng Biotechnol. 2019 Aug 23;7:205. doi: 10.3389/fbioe.2019.00205. eCollection 2019.

本文引用的文献

1
Dynamic in vivo biocompatibility of angiogenic peptide amphiphile nanofibers.血管生成肽两亲性纳米纤维的动态体内生物相容性
Biomaterials. 2009 Oct;30(31):6202-12. doi: 10.1016/j.biomaterials.2009.07.063. Epub 2009 Aug 15.
5
Bones of contention: marrow-derived cells in myocardial regeneration.争论焦点:心肌再生中的骨髓来源细胞
J Mol Cell Cardiol. 2008 Jun;44(6):950-953. doi: 10.1016/j.yjmcc.2008.03.007. Epub 2008 Mar 15.
9
Bone marrow cells adopt the cardiomyogenic fate in vivo.骨髓细胞在体内会转变为心肌生成命运。
Proc Natl Acad Sci U S A. 2007 Nov 6;104(45):17783-8. doi: 10.1073/pnas.0706406104. Epub 2007 Oct 26.
10
The roles of mesenchymal stem cells (MSCs) therapy in ischemic heart diseases.间充质干细胞(MSCs)疗法在缺血性心脏病中的作用。
Biochem Biophys Res Commun. 2007 Jul 27;359(2):189-93. doi: 10.1016/j.bbrc.2007.05.112. Epub 2007 May 25.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验